Related Experiment Video
Updated: Nov 14, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Racing for COVID-19 Vaccine and Cure: Lessons and Tragedies in Human Subject Research
Amar M Salam1,2,3, Alison S Carr2
1Department of Cardiology, Al-Khor Hospital, Hamad Medical Corporation, Doha, Qatar.
Abstract:
Pressured by the enormous human and economic costs of the COVID-19 pandemic, certain countries and political figures have advocated the use of drugs and vaccines that did not go through the required regulatory stages of the development. Although the reason for bypassing these stages in a race to produce a treatment and vaccine for the COVID-19 patients could have been caused by good intentions to stop the human suffering from the pandemic, nonetheless, history has taught us that the results of this action could be catastrophic. In this article, we briefly review the lessons and tragedies in the evolution of human subject research regulations emphasizing the need for the proper evaluation of drugs and vaccines for COVID-19.
Insights
Rushing COVID-19 drugs and vaccines without regulatory approval risks repeating past research tragedies. Proper evaluation is crucial to prevent catastrophic outcomes and ensure patient safety during public health crises.
Area of Science:
- Medical ethics
- Public health policy
- Drug development regulation
Background:
- The COVID-19 pandemic created immense pressure for rapid medical interventions.
- Some nations and leaders proposed using unapproved drugs and vaccines.
- Historical precedents demonstrate the dangers of circumventing regulatory processes.
Purpose of the Study:
- To review historical lessons from human subject research.
- To emphasize the necessity of rigorous evaluation for COVID-19 treatments and vaccines.
- To caution against bypassing established regulatory pathways.
Main Methods:
- Historical review of human subject research regulations.
- Analysis of ethical considerations in drug and vaccine development.
- Case study examination of past research tragedies.
Main Results:
- Bypassing regulatory stages, even with good intentions, can lead to severe negative consequences.
- The evolution of research regulations highlights the importance of ethical oversight.
- Unverified medical interventions pose significant risks to public health.
Conclusions:
- Proper evaluation of drugs and vaccines is paramount for public safety.
- Adherence to regulatory standards is essential, especially during pandemics.
- Learning from historical research ethics failures is critical for future pandemic response.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethics in Research
Clinical Trials: Overview
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

